<DOC>
	<DOCNO>NCT00680602</DOCNO>
	<brief_summary>First line treatment fo Obsessive Compulsive Disorder ( OCD ) Selective Serotonin Recapture Inhibitors ( SSRIs ) Cognitive Behaviour Therapy ( CBT ) include exposure response prevention . The aim present study evaluate clinical efficacy GCBT SSRIs OCD patient . Other clinical trial compare treatment , OCD patient without psychiatric disorder . In study patient current age 18 65 year , YBOCS score least 16 psychiatric comorbidities exclude . Exclusion criterion : OCD secondary brain trauma , stroke malformation ; current abuse alcohol psychoactive substance , current presence psychotic symptom , suicidal risk , psychiatric clinical comorbidity might get bad medication use trial . So , present study investigate efficacy treatment heterogeneous OCD population , try identify usual treatment efficient apply public health system treat patient OCD diagnosis . Patients randomize GCBT SSRI , treatment evaluate researcher blind treatment receive .</brief_summary>
	<brief_title>Group Cognitive Behavioral Therapy Versus Fluoxetine Obsessive-Compulsive Disorder : Practical Trial</brief_title>
	<detailed_description>During last decade , different pharmacological psychotherapeutic strategy use treat patient obsessive compulsive disorder ( OCD ) . Drugs inhibit serotonin recapture cognitive behavior therapy , include exposure response prevention cognitive strategy , efficient treatment far . This study 's aim compare group cognitive-behavior therapy standard pharmacological treatment ( SRIs ) world real population , use broad inclusion criterion . DSM-IV diagnostic criterion OCD use ( APA , 1994 ) patient interview follow instrument : SCID-I Y-BOCS . Inclusion criterion : ( 1 ) OCD diagnosis , ( 2 ) YBOCS score ≥ 16 ( patient obsession compulsion ) ≥ 10 ( patient obsession compulsion ) , ( 3 ) inform consent participate clinical trial . Exclusion criterion : ( 1 ) patient clinical neurological disease may worsen medication include treatment protocol , ( 2 ) Current substance dependence , ( 3 ) Current psychotic symptom , ( 4 ) Current suicide risk . Patients randomize block 12 stratification follow parameter : current SSRI , age , sex previous response treatment . Rates improvement base result YBOCS score obsession compulsion result clinical global impression scale . Pos-treatment measure assess psychiatrist psychologist involve patient treatment blind treatment receive patient . The patient consider responsive treatment present reduction YBOCS score ≥ 35 % initial score CGI score 1 ( much improve ) 2 ( much improve ) . The result study help u identify good health politics plan heterogeneous OCD population . So , improve knowledge efficacy first line treatment real world OCD population .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Fluoxetine</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Having diagnose primary OCD accord criterion set forth DSMIV ; Current symptom cause significant distress ( YBOCS score great 16 ) ; Not receive current adequate treatment ; Accepting participate study Having clinical neurological disease might worsen medicine include treatment protocol ; Presenting current substance dependence abuse ; Exhibiting current psychotic symptom ; currently risk suicide ; And , pregnant intention become pregnant prior end treatment protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>behavior therapy</keyword>
	<keyword>group therapy</keyword>
	<keyword>psychopharmacology</keyword>
</DOC>